Illumina expands Billion Cell Atlas program with new AI drug developers
Go back to Illumina expands Billion Cell Atlas program with new AI drug developers| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 190.87 -1.66 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $192.53 | 52 Week High | $196.47 | |||
| Open | $190.00 | 52 Week Low | $127.10 | |||
| Day High | $194.65 | P/E | 212.08 | |||
| Day Low | $188.00 | EPS | $0.90 | |||
| Volume | 1,551,504 | |||||
